Tazarotene: all 41 studies that test it

Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• Topical Tazarotene Vs Placebo In Hand-Foot-Skin ReactionsTerminatedNCT04071756Phase 2Results posted
• A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (302)CompletedNCT03168334Phase 3Results posted
• A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (301)CompletedNCT03168321Phase 3Results posted
• Safety and Efficacy of IDP-123 Lotion to Tazorac® Cream, in the Treatment of Acne VulgarisCompletedNCT02938494Phase 2Results posted
• A Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both to a Placebo Control in the Treatment of Acne VulgarisCompletedNCT02886715Phase 3Results posted
• A Study Comparing Tazarotene Cream 0.05% to TAZORAC® (Tazarotene) Cream 0.05% and Both to a Placebo Control in the Treatment of Plaque PsoriasisCompletedNCT02886702Phase 3Results posted
• Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque PsoriasisCompletedNCT02785172Phase 2Results posted
• Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque PsoriasisCompletedNCT02785159Phase 2Results posted
• Safety and Efficacy of IDP-118 in Participants With Plaque PsoriasisCompletedNCT02462122Phase 3Results posted
• Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque PsoriasisCompletedNCT02462083Phase 3Results posted
• Safety and Efficacy of IDP-118 in the Treatment of Plaque PsoriasisCompletedNCT02462070Phase 3Results posted
• A Study To Evaluate The Safety And Therapeutic Equivalence of Tazarotene Foam 0.1% in Subjects With Acne VulgarisCompletedNCT02267746Phase 3Results posted
• Safety and Efficacy of IDP 118 in the Treatment of Plaque PsoriasisCompletedNCT02045277Phase 2Results posted
• Acitretin or Tazarotene Gel and Excimer Laser for Treatment of PsoriasisTerminatedNCT01094717Not applicableResults posted
• Photodynamic Therapy With Levulan® +/- Topical Retinoid Pre-Treatment In The Treatment Of Actinic KeratosesCompletedNCT01053000Not applicableResults posted
• Dapsone Gel 5% and Tazarotene Cream 0.1% Versus Tazarotene Cream 0.1% Monotherapy for Facial Acne VulgarisCompletedNCT00834210Phase 4Results posted
• Safety and Efficacy of Tazarotene Cream 0.1% Compared With Adapalene Gel 0.3% in the Treatment of Moderate to Severe Facial Acne VulgarisTerminatedNCT00829049Phase 4Results posted
• Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and BackCompletedNCT00783965Phase 2Results posted
• Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With AcneCompletedNCT00713609Phase 2Results posted
• Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo MalignaCompletedNCT00707174Not applicableResults posted
• Sorafenib-induced Hand- Foot Skin Reaction TreatmentTerminatedNCT00667589Phase 2Results posted
• Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the FaceCompletedNCT00489086Phase 2Results posted
• Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPFCompletedNCT06331624Phase 2
• Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in PsoriasisCompletedNCT06042647Phase 4
• Comparison Of Efficacy Of Tazarotene 0.045% Vs Halobetasol Propionate 0.01% Lotion For Treatment of Scalp PsoriasisCompletedNCT06015152Not applicable
• Tazarotene 0.045% Lotion for Treating PIE and PIH in Subjects With AcneCompletedNCT05704114Phase 4
• Comparing the Efficacy of Topical Tazarotene Gel 0.1% v/s Microneedling in Atrophic Post Acne ScarsCompletedNCT05573425Phase 2/3
• Efficacy of Tazarotene in Treatment of Verruca PlanaStatus unknownNCT05314127Phase 2
• A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque PsoriasisCompletedNCT03988439Phase 4
• Comparison Between Microneedling Daycare Procedure and Tazarotene 0.1% Gel Local Application in Acne ScarringCompletedNCT03170596Not applicable
• Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque PsoriasisCompletedNCT03058744Phase 1
• Absorption and Systematic Pharmacokinetics of IDP-123 Lotion in Comparison With Tazorac CreamCompletedNCT02849873Phase 1
• Tazarotene Plus Clindamycin vs. Adapalene Plus Clindamycin in the Treatment of Facial Acne VulgarisCompletedNCT02721173Phase 4
• Study to Compare the Safety and Efficacy of IDP-123 Lotion to Tazorac Cream in the Treatment of Acne VulgarisStatus unknownNCT02525822Phase 2
• A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne VulgarisCompletedNCT02411955Phase 1
• Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne VulgarisCompletedNCT02218034Phase 1
• A Study to Evaluate the Potential of Tazarotene Foam to Cause an Allergic Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers.CompletedNCT01119651Phase 1
• A Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne VulgarisCompletedNCT01019603Phase 1
• Tazarotene 0.1% Cream For the Treatment of Cutaneous T-Cell Lymphoma: A Prospective StudyStatus unknownNCT00779896Phase 1/2
• Efficacy and Safety Study of Tazarotene (Tazorac) for the Treatment of Brittle NailsCompletedNCT00648986Phase 4
• The Effect Of A Controlled Daily Skin Care Regimen On Retinoic Acid ToleranceCompletedNCT00440024Not applicable

← Tazarotene overview